GlassScriptPhysician profile
Ravneet Grewal
NPI 1649271750
$9,876.32
in general payments reported to CMS, 2019-2025
76 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,364 · 2020: $769 · 2021: $1,325 · 2022: $2,312 · 2023: $1,651 · 2024: $1,239 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,008 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,008.43 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,659.29 | 2019-2025 | Darzalex, Imbruvica, Rybrevant |
| Pharmacyclics LLC, An Abbvie Company | $444.58 | 2019-2023 | Imbruvica |
| Abbvie INC. | $438.70 | 2022-2025 | |
| Pfizer INC. | $386.04 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $383.00 | 2019-2025 | |
| Celgene Corporation | $376.61 | 2019-2023 | Opdualag |
| Seagen INC. | $349.40 | 2019-2023 | Adcetris, Tukysa |
| Eisai INC. | $344.55 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $315.99 | 2019-2024 | Onglyza, Calquence |
| E.R. Squibb & Sons, L.L.C. | $311.80 | 2019-2024 | Opdivo |
| Asd Specialty Healthcare, LLC | $294.91 | 2022-2024 | |
| Global Blood Therapeutics, INC. | $264.12 | 2020-2022 | |
| Incyte Corporation | $261.65 | 2019-2025 | Jakafi, Niktimvo |
| Alexion Pharmaceuticals, INC. | $260.70 | 2019-2024 | Ultomiris |
| Janssen Pharmaceuticals, INC | $221.54 | 2019-2024 | Xarelto |
Show all 76 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravneet Grewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.